En litteraturstudie om methicillinresistent Staphylococcus pseudintermedius (MRSP) : klassificering, resistensmekanismer, riskfaktorer och klonal distribution by Fang, Yusi
 
 
1 
 
Fakulteten för veterinärmedicin 
och husdjursvetenskap 
Institutionen för Biomedicin och veterinär 
folkhälsovetenskap 
 
 
 
 
 
 
 
 
 
 
 
A literature study on Methicillin-resistant 
Staphylococcus pseudintermedius (MRSP): 
classification, resistance mechanisms, risk factors 
and clonal distribution. 
Yusi Fang 
 
 
 
 
Uppsala 
2015 
Kandidatarbete15 hp inom veterinärprogrammet 
 
Kandidatarbete 2015:23 
  
   
  
A literature study on Methicillin-resistant 
Staphylococcus pseudintermedius (MRSP): 
classification, resistance mechanisms, risk 
factors and clonal distribution. 
En litteraturstudie om methicillinresistent 
Staphylococcus pseudintermedius (MRSP): 
klassificering, resistensmekanismer, riskfaktorer och 
klonal distribution 
 
Yusi Fang 
 
 
 Handledare: Susanna Sternberg Lewerin, institutionen för biomedicin och veterinarinär folkhälsovetenskap 
 
 
Examinator: Eva Tydén, institutionen för biomedicin och veterinär 
folkhälsovetenskap 
Kandidatarbete i veterinärmedicin 
 
Omfattning: 15 hp 
Nivå och fördjupning: grund nivå, G2E 
Kurskod: EX0700 
 
Utgivningsort: Uppsala 
Utgivningsår: 2015 
Delnummer i serie: 2015:23
 
 
Elektronisk publicering: http://stud.epsilon.slu.se
 
 
Key words: MRSP, resistance, dog, SCCmec, 
 
Nyckelord: MRSP, resistens, hund, SCCmec
 
Sveriges lantbruksuniversitet 
Swedish University of Agricultural Sciences 
Fakulteten för veterinärmedicin och husdjursvetenskap 
Institutionen för biomedicin och veterinär folkhälsovetenskap 
   
 Table of Contents 
 
ABSTRACT ............................................................................................................................................ 1 
SAMMANFATTNING ........................................................................................................................... 2 
INTRODUCTION ................................................................................................................................... 3 
MATERIALS AND METHODS ............................................................................................................ 3 
LITERATURE STUDY .......................................................................................................................... 3 
What is antimicrobial resistance? ....................................................................................................... 3 
Staphylococcus pseudintermedius – Characteristics and classification .............................................. 5 
Resistance to beta-lactams – mechanisms .......................................................................................... 5 
Subtyping ............................................................................................................................................ 6 
Resistance to non-betalactams ............................................................................................................ 6 
MIC and antibacterial susceptibility test ............................................................................................ 6 
The emergence of MRSP and horizontal gene transfer (HGT) .......................................................... 7 
Major risk factors affecting selection of MRSP ................................................................................. 7 
Clonal distribution of MRSP around the world .................................................................................. 8 
Zoonotic aspects of MRSP ................................................................................................................. 9 
DISCUSSION .......................................................................................................................................... 9 
REFERENCES ...................................................................................................................................... 12 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
ABSTRACT 
The increased frequency of reported Methicillin-resistant Staphylococcus pseudintermedius 
(MRSP) is of great concern to small animal healthcare due to limited options of antimicrobial 
therapy. The aim of this literature study is to investigate 1) characteristics and classification of 
S. pseudintermedius, 2) resistance mechanisms and emergence of MRSP, 3) risk factors for 
selection of MRSP, and 4) clonal distribution around the world. S. pseudintermedius is a skin 
and mucosal commensal in healthy dogs and cats, but can cause infections, including 
pyoderma.  
Beta-lactam antibiotics inhibit bacterial growth by binding to the penicillin binding protein 
(PBP), a vital enzyme in the synthesis of the bacterial cell wall. Methicillin-resistance in S. 
pseudintemedius is encoded by the mecA gene, that expresses modified PBP, named PBP2a or 
PBP2’, with a lower affinity for beta-lactams. The mecA gene is located on the staphylococcal 
chromosomal cassette, a mobile genetic element. In addition to beta-lactams, MRSP can be 
resistant to other classes of antibiotics drugs.  
The main risk factors for selection of MRSP are hospitalization, veterinary visits and former 
treatment with antibiotics. MRSP infection is therefore considered to be a nosocomial 
infection. The major clonal lineage predominant in Europe is ST71-J-t02-II–III; whilst in 
North America it is ST68-C-t06-V. Colonization of S. pseudintermedius in human is rare, and 
only one case of MRSP has been found up to date. Resistance genes are believed to be shared 
between species of staphylococci by horizontal gene transfer. However, more studies are 
needed to fully understand the mechanisms of horizontal gene transfer of the mecA gene. 
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SAMMANFATTNING 
Ett växande problem inom smådjursveterinärmedicinen är methicillinresistent Staphylococcus 
pseudintermedius (MRSP) som begränsar valet av antibiotikum vid behandling. Syftet med 
denna litteraturstudie är att kartlägga 1) egenskaper och klassificering av S. pseudintermedius, 
2) resistensmekanismer och uppkomst av MRSP, 3) riskfaktorer som selekterar för MRSP och 
4) den klonala distributionen i världen. S. pseudintermedius är normalflora på hud och 
slemhinnor hos friska hundar och katter, men kan även orsaka opportunistiska infektioner, 
bl.a. pyodermi.  
Antibiotikaklassen beta-laktamer utövar sin antibakteriella effekt genom att inhibera 
penicillinbindande protein (PBP), ett enzym involverad i cellväggssynten. 
Methicillinresistensen hos MRSP kodas av mecA-genen, som ger upphov till modifierat PBP, 
kallat PBP2a eller PBP2’, med en lägre affinitet för beta-laktamer. MecA genen är belägen på 
stafylokockens kromosomkassett, ett mobilt genelement. MRSP kan vara resistenta mot andra 
antibiotikaklasser utöver beta-laktamer.  
De riskfaktorer som selekterar för MRSP är sjukhusvistelse, veterinärbesök och tidigare 
antibiotikabehandling. Därför anses MRSP-infektioner vara nosokomiala smittor. Den klon 
som dominerar i Europa är ST71-J-t02-II–III, och ST68-C-t06-V dominerar i Nordamerika. S. 
pseudintermedius koloniserar sällan människor, och endast ett fall av MRSP hos människa 
har rapporterats. Olika arter av stafylokocker tros dela resistensgener genom horisontell 
genöverföring. Dock behövs fler studier för att klarlägga mekanismer för horisontell 
genöverföring av mecA-genen mellan stafylokocker.  
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INTRODUCTION 
The rate and extent of antimicrobial resistance in bacteria has increased in recent years. The 
World Health Organization (WHO) defines antimicrobial resistance as the “…resistance of a 
microorganism to an antimicrobial drug that was originally effective for treatment of 
infections caused by it” (WHO, 2014). The use of antimicrobial drugs selects for resistant 
strains of bacteria already present in the population, rather than actually inducing resistance 
(Hirsh et al., 2004; Quinn et al., 2011). 
Since the first description of Staphylococcus pseudintermedius as a novel species in 2005 
(Devriese et al., 2005), methicillin-resistant Staphylococcus pseudintermedius (MRSP) was 
reported with increased frequency in the following year (van Duijkeren et al., 2011). The 
bacterium is both a commensal on dogs, and a pathogen causing canine pyoderma and wound 
infections (van Duijkeren et al., 2011). Moreover, MRSP are often resistant to several 
different classes of antibiotics (Perreten et al., 2010). This limits the treatment options and is 
considered a threat to small animal therapy in veterinary medicine (van Duijkeren et al., 
2011). 
This literature study aims to investigate the following:  
1) Characteristics and classification of S. pseudintermedius  
2) Emergence of MRSP and resistance mechanisms  
3) Risk factors for selection of MRSP  
4) Clonal distribution around the world  
MATERIALS AND METHODS 
Databases used were PubMed, Web of Science and Primo.  
The main search terms were (MRSP OR "Methicillin-resistant staphylococcus 
pseudintermedius"), (antibio* OR antimicr*), (dog OR Canine), geneti*, prevalence, SCC, 
mecA and horizontal gene transfer.  
LITERATURE STUDY 
What is antimicrobial resistance? 
Resistance to antimicrobial drugs can occur due to acquired resistance, either by mutation in 
the chromosomal DNA, or by acquiring genetic material. Chromosomal mutation often leads 
to a change in the bacterial structure, e.g. altered antimicrobial target proteins. These rare, 
spontaneous changes in the bacterial DNA are due to mistakes during DNA replication, and 
are not caused by the presence of antibiotics. The mutations can be either beneficial, in this 
case by causing antimicrobial resistance, or disadvantageous to the survival of the bacteria, 
even lethal. Mutations in genes leading to expression of efflux proteins can induce multiple 
antibiotic resistances. (Hirsh et al., 2004; Quinn et al., 2011) 
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The mechanism of more importance to the development of antibiotic resistance is the 
exchange of transferable DNA structures, usually plasmids. These mobile gene elements 
carrying resistance genes can be spread to other bacteria by (see Figure 1): 
• Transduction – DNA incorporated in bacterial phages (virus that infects bacteria) and 
transferred between bacteria by phages.  
• Conjugation – The transfer of plasmid or chromosomal DNA from donor to recipient 
through a sex pilus. 
• Transformation – The ability of certain bacteria genera to pick up naked DNA from 
the environment. 
• Transposition – Gene segments can change position within the bacterial genom. 
• Integrons – Consists of an intergrase gene that can capture gene cassettes coding for 
antibiotic resistance (Hirsh et al., 2004; Quinn et al., 2011). 
 
            
 
Figure 1. Mobile gene elements. By Yusi Fang modified from (2013MMG320B, 2013). 
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Staphylococcus pseudintermedius – Characteristics and classification  
While S. aureus is the predominant Staphylococcus species colonizing and infecting humans 
(Sung et al., 2008), S. pseudintermedius is the more important pathogen in dogs (van 
Duijkeren et al., 2011). 
S. pseudintermedius is a coagulase-positive facultative anaerobe gram-positive coccus. It 
appears as small, round, light grey, opaque colonies with a diameter of 1–2 mm when 
cultured. The bacteria show a double zone of haemolysis on bovine blood agar: an inner zone 
of complete haemolysis caused by α-haemolysin, and an outer zone of partial haemolysis 
caused by β-haemolysin. The bacteria are catalase-positive and oxidase-negative. Their 
micromorphology is cocci arranged in groups (VetBact, 2014). 
S. pseudintermedius is a commensal on skin and mucosa of healthy dogs and cats, and can be 
isolated from the nares, mouth, anus, groin and forehead (Kadlec & Schwarz, 2012). In rare 
cases, the bacteria have been found in humans and horses (Kadlec & Schwarz, 2012). As a 
pathogen, it can cause opportunistic infections on the skin, including pyoderma, otitis externa, 
wound infections, abscesses, infections on other body tissues and cavities, and post-operative 
wound infections (Weese & van Duijkeren, 2010; van Duijkeren et al., 2011). Kawakami et 
al. (2010) state that S. pseudintermedius is considered to be the most important pathogen 
causing canine pyoderma.  
S. intermedius was first described in the 1970s based on phenotypical characteristics. In 2005, 
S. pseudintermedius was discovered as a novel species using the technique of 16S rRNA gene 
sequence analysis. S. intermedius was reclassified into three closely related clusters: S. 
intermedius, S. pseudintermedius and S. delphini, which together make up the Staphylococcus 
intermedius group (SIG) (Sasaki et al., 2007). The different species within the SIG group are 
difficult to distinguish by using standardized routine diagnostic methods only. Since S. 
pseudintermedius is the cluster that colonizes and infects dogs, it is recommended to classify 
all strains of the SIG group found on dogs as S. pseudintermedius, if molecular analysis has 
not been carried out. (Weese & van Duijkeren, 2010; van Duijkeren et al., 2011) 
Resistance to beta-lactams - mechanisms 
Beta-lactam antibiotics inhibit bacterial growth by binding to the penicillin binding protein 
(PBP), a vital enzyme in the synthesis of the bacterial cell wall (Weese & van Duijkeren, 
2010). In the 1980s, McDougal and Thornsberry (1986) found that staphylococci started to 
show resistance against penicillin and cephalosporin. The mechanism behind the resistance 
was that the enzyme beta-lactamase produced by some strains of staphylococci were able to 
hydrolyse and thereby inactivate beta-lactam antibiotics. Beta-lactamase inhibitors, e.g. 
clavulanic acid in combination with beta-lactam antibiotics, have shown to have some effect 
on beta-lactamase producing strains (McDougal & Thornsberry, 1986). 
Methicillin-resistant Staphylococcus aureus (MRSA) and MRSP show resistance via a 
different mechanism in addition to beta-lactamase production, by expressing a modified PBP, 
known as PBP2a or PBP2’, with a lower affinity for beta-lactams. The antibiotics cannot 
inhibit the enzyme and fail to exercise its inhibitory effect on bacterial growth (Hanssen & 
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Sollid, 2006; Weese & van Duijkeren, 2010). MRSP has become a significant problem 
worldwide due to the limited amount of antibiotic for the treatment of S. pseudintermedius 
infections (Solyman et al., 2013). 
Methicillin-resistance in S. pseudintemedius is encoded by the mecA gene. It is located on the 
staphylococcal chromosomal cassette (SCC). The different types of SCCmec elements found 
in MRSP are SCCmec II-III, SCCmec III, SCCmec IV, SCCmec V, SCCmec VII and non-
typeable cassettes (van Duijkeren et al., 2011).  
Subtyping 
Other methods in addition to SCCmec typing are used for subtyping, identification and 
classification of MRSP. Multilocus sequence typing (MLST) is a method used to identify 
sequence types (designated ST) and hence the genetic structure, as well as tracking the clonal 
distribution of MRSP (Solyman et al., 2013). Typing scheme for staphylococcal protein A 
(spa) gene (designated t) and pulse-field gel electrophoresis (PFGE) are used to compare 
isolates (Ruscher et al., 2010; van Duijkeren et al., 2011). 
Resistance to non-betalactams 
MRSP are considered to be resistant to all beta-lactam antibiotics. Many isolates also show 
resistance against other classes of antibiotics, e.g. tetracyclines, macrolides, lincosamides, 
aminoglycosides, trimethoprim, chloramphenicol and fluoroquinolones (Perreten et al., 2010; 
Weese & van Duijkeren, 2010; van Duijkeren et al., 2011; Cain, 2013). Different resistance 
genes mediate different resistance mechanisms, including membrane-associated efflux, 
altered target molecules, enzyme inactivation, protection proteins and altered membrane 
channel permeability (Perreten et al., 2010; Weese & van Duijkeren, 2010; van Duijkeren et 
al., 2011; Cain, 2013). 
MIC and antibacterial susceptibility test 
Minimal inhibitory concentration (MIC) is the lowest concentration of an antibacterial agent 
that inhibits growth of a bacterial isolate (Quinn et al., 2011). 
Broth dilution, disc diffusion and agar gradient are different tests to determine susceptibility 
of a bacterial isolate to different antibiotics in vitro. In broth dilution, a standard amount of 
bacteria is added to broth with varying or two-fold dilution of antibiotic concentrations. Broth 
dilution is considered to be an accurate method in finding the lowest concentration of an 
antibiotic that inhibits the growth of the tested bacteria. (Engelkirk & Duben-Engelkirk, 2008; 
Quinn et al., 2011) 
The commonly used Kirby-Bauer disc diffusion method is a relatively simple and economical 
method, most suitable for testing rapidly aerobic bacteria. The bacterial sample is spread on 
an agar plate and antimicrobial discs with specific amounts of antibiotics are placed on the 
inoculated surface. After incubation, the diameter of the inhibition zone of each antibiotic is 
measured in millimetres and compared to international standards. (Quinn et al., 2011) 
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The Clinical and Laboratory Standards Institute (CLSI) recommends using a breakpoint for 
oxacillin (a beta-lactam antibiotic) susceptibility of S. pseudintermedius equivalent to the 
breakpoint of S. aureus, a value >2 mg/l (Bemis et al., 2009; A. Bergström et al., 2012). 
However, a study by Bemis et al. (2009) concluded that the criteria stated by CLSI were not 
sufficient to detect all mecA-associated resistance in S. pseudintermedius. Instead, oxacillin 
disk diffusion zone diameters of ≤17 mm and a oxacillin MIC of ≥ 0.5 µg/ml is found to 
accurately determine oxacillin resistance in S. pseudintermedius mediated by the mecA gene. 
The emergence of MRSP and horizontal gene transfer (HGT) 
Methicillin-resistant canine staphylococci were first isolated in the 1980s by Pellerin et al., 
(1998) in France. The bacteria were reported to be resistant to penicillin, oxacillin and 
cloxacillin. In 1999, Gortel et al. (1999) suggested that this resistance was mediated by the 
mecA gene, since isolates possessing the mecA gene were more likely to be resistant to several 
kinds of beta-lactam antibiotics than isolates lacking the mecA gene. The mecA gene is 
located on the mobile genetic element SCCmec. Since the first reports, MRSP has been 
reported with increased frequency (Weese & van Duijkeren, 2010). 
Bannoehr et al. (2007) studied 105 isolates of the SIG group, obtained from both healthy and 
diseased animals from several different countries around the world. By sequencing the mecA 
gene, they found in their study that the mecA genes of S. pseudintermedius were closely 
matched with mecA genes in S. aureus. A recent study by McCarthy et al. (2014) investigated 
the genomic background of 12 S. pseudintermedius isolates with varying resistance degree 
from several different countries, including the UK and Germany. The authors suggested that 
resistance was spread amongst S. pseudintermedius through horizontal gene transfer (HGT) 
with mobile genetic elements.  Resistance to beta-lactams was not likely to be mediated by 
plasmid conjugation since the plasmids in the investigated strains did not carry any resistance 
genes. Instead, the authors concluded that HGT is most likely to be mediated by transposons 
and bacteriophage transduction. The SCCmec element of S. pseudintermedius was highly 
homologous with the ones of S. aureus and coagulase negative staphylococcus (CoNS), such 
as S. epidermidis and S. haeomlyticus (McCarthy et al., 2014). Together with the study by 
Bannoehr et al. (2007), this supports the hypothesis of HGT between species of 
staphylococci. 
However, Wang et al. (2012) do not believe SCCmec of S. pseudintermedius are acquired 
from S. aureus, since the SCCmec type in their study differed from the SCCmec types 
isolated from Methicillin resistant Staphylococcus aureus in their previous study (Zhang et 
al., 2011).  
Major risk factors affecting selection of MRSP  
A recent case-control study by Lehner et al. (2014) examined 20 different variables of risk 
factors for MRSP in dogs and cats in Germany. Samples were taken from a university 
teaching hospital and non-university teaching clinics. The disc diffusion method was used to 
determine antimicrobial resistance. In the univariable regression analysis, 11 variables were 
found to significantly increase the odds ratio of MRSP. However in the multivariable logistic 
regression analysis, the findings of interest were that animals that were hospitalized or 
 8 
made frequent visits to a veterinarian had a higher risk of carrying MRSP. Also, the 
prevalence of MRSP was higher in the university teaching hospital (87/360, 24.2 %) than the 
non-university veterinary clinics (52/680, 7.7 %). The authors concluded that MRSP is to be 
considered a nosocomial (healthcare-associated) infection, where hospitalization and frequent 
veterinary visit are the major risk factor for MRSP infection. A study by Nienhoff et al. 
(2011) including 814 dogs found treatment with antibiotics as a main risk factor, in addition 
to hospitalization and recent veterinary contact. 
Loeffler et al. (2007) studied 12 patients with recurrent pyoderma or otitis that had been 
treated with systemic beta-lactams or fluoroquinolones for bacterial infection. S. intermedius 
resistant to at least 5 antimicrobial classes was found, 11 isolates were resistant to antibiotics 
licensed for systemic use in most European countries. This study also suggests that the use of 
antibiotics during a long period of time select for multiresistant S. intermedius.  
Clonal distribution of MRSP around the world  
An international multicentre study by Perreten et al. (2010), aimed to map the phenotypic and 
genotypic resistance profiles of MRSP colonizing dogs in North America and several 
different European countries. The study included 103 isolates of MRSP from healthy dogs 
and dogs with clinical symptoms. The authors found that ST71-J-t02-II–III was the clonal 
MRSP lineage that was predominant in Europe, whilst in North America it was the ST68-C-
t06-V clonal lineage. All isolates were found to be carrying the mecA gene and were resistant 
to oxacillin. Both clones were also resistant to several other antibiotic classes, by different 
resistance genes. Some MRSP isolates belonged to unique sequence types (ST69, ST113, 
ST114 and ST116). Haenni et al. (2014) found the ST71–t02–II-III clone in France, the same 
European clone described by Perreten et al. (2010). Another study, in Germany and several 
other European countries, found MRSP isolates belonging to the sequence type ST71 and the 
majority harboured spa type t02 (Ruscher et al., 2010). However, in this study SCCmec III 
was found to be the most prevalent SCCmec type, differing from the findings of Haenni et al. 
(2014) and Perreten et al. (2010). 
Wang et al. (2012) were the first to investigate MRSP from canine pyoderma in China and 
identified ST71-t06-II-III as the most prevalent genotype. A total of 260 pyoderma samples 
were taken from dogs in northern China. Broth dilution was carried out to determine 
antibiotic susceptibility. Thirty-three isolates were identified as MRSP, all harbouring the 
mecA gene encoding resistance against oxacillin. In addition, all isolates were resistant to 
tetracycline, erythromycin (macrolide) and clindamycin (lincosamide). Wang et al. found the 
same ST type (ST71) as the European ST71-J-t02-II–III clone found by Perreten et al. (2010), 
but with a different spa type (t06 in China and t02 in Europe).  
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Zoonotic aspects of MRSP 
Colonization of S. pseudintermedius is very rare in humans unlike S. aureus. Therefore, the 
importance of MRSP as a zoonotic agent is not as great as that of MRSA. However, S. 
pseudintermedius is found more often in owners of dogs with deep pyoderma. The 
colonization is usually transient, since humans are not natural hosts of the bacteria. (van 
Duijkeren et al., 2011) 
Stegmann et al. (2010) were the first to report a case of human infection with MRSP. The 
isolate was identified as ST71-t02-J with SCCmec II–III, the sequence type circulating among 
dogs in Europe. The patient was the owner of a dog, which needed home care and underwent 
several antibiotic treatments. The dog was euthanized and samples could not be obtained, and 
thus it was not possible to determine the source of infection. However, transmission of MRSP 
from the dog to its owner is a possibility. Stegmann et al. (2010) regard the zoonotic aspect of 
MRSP as an increasing problem, and think that “last resort antibiotics” as treatment for 
methicillin-resistant staphylococci should be saved for human use, rather than treatment of 
animals.  
S. pseudintermedius has some importance in dog-bite wounds were it can be an opportunistic 
pathogen. S. pseudintermedius can be misidentified as S. aureus in dog-bite wounds on 
humans and the prevalence may therefore be underreported. (Weese & van Duijkeren, 2010) 
DISCUSSION 
As MRSA is considered to be a major nosocomial pathogen amongst humans worldwide 
(Graffunder & Venezia, 2002), MRSP could be the corresponding threat amongst dogs in 
veterinary medicine. Lehner et al. (2014) and Nienhoff et al. (2011) found significant 
correlation between MRSP infection and hospitalization and veterinary visits. One reason 
could be the direct transmission between dogs in the veterinary clinics, since dogs are found 
to carry MRSP for at least six months after acquisition (A. Bergström et al., 2012). Another 
reason is the possible risk of indirect transmission between dogs via environmental surfaces in 
hospitals. Singh et al. (2013) aimed to determine personnel clothing as a risk factor for the 
spread of methicillin-resistant staphylococci. Correlation was found for MRSA but not 
MRSP. However, the study included a very small sample size (n=4 in the group with MRSA) 
and it is therefore hard to draw any definite conclusion. 
In an outbreak of MRSA infection among horses in a Swedish veterinary hospital, 11% of the 
environmental samples, from walls, floor, treatment areas, doorknobs etc. were positive for 
MRSA, and the hospital environment can therefore be considered a major risk factor for 
indirect transmission of MRSA (K. Bergström et al., 2012). The fact that a similar correlation 
has not yet found between MRSP and environmental contamination should not exclude the 
possibility of this being a risk factor, since the two species of staphylococci share many 
characteristics. Anyhow, more emphasis should be put on the importance of isolation of 
infected individuals and hygiene demands of staff, equipment and environment.  
Antibiotic use should also be considered as a risk factor, since it selects for resistant bacteria. 
Both Nienhoff et al. (2011) and Loeffler et al. (2007) found significant correlations between 
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antibiotics treatment and the carriage of MRSP. In Sweden, it is recommended to avoid 
antibiotic treatment of patients with MRSP to reduce the risk of further development of 
resistance (SVA, 2014). However, there are difficulties in standardizing the studies for 
comparison between different countries, due to many factors involved, e.g. antibiotics 
available in the country, local legislation, personal experience and preferences affect the use 
and choice of antibiotics.  
Solyman et al. (2013) believe that the understanding of clonal distribution of MRSP around 
the world provides great possibilities for control programs to reduce the spread. The 
information is also useful for the development of new treatment methods, e.g. vaccines or 
phage therapy that can target the specific clone present. 
 
Perreten et al. (2010) found the European ST71-t06-II-III clone to be multi-resistant to several 
classes of antibiotics, and to have harboured more resistance genes than other minor sequence 
types. The results of Perreten et al., (2010) and Wang et al. (2012) show ST71 to be a 
successful MRSP type spread around large parts of the world. Since Lehner et al. (2014), 
Nienhoff et al. (2011) and Loeffler et al. (2007) found hospitalization, veterinary visits and 
antibiotic treatment to be the major risk factors for infections with MRSP, it is likely that 
selection for resistance takes place in the hospital environment. In the presence of these risk 
factors and a selection pressure, the MRSP are more likely to acquire and harbour other 
resistance genes. Although carrying excess genes is costly for the bacterium, it is 
advantageous in such environments. Therefore, the predominant clones become more 
successful and harder to eradicate. 
 
There are several studies examining the clonal distribution of MRSP around the world, but 
studies on the mechanism of spread have not been found. The spa types and SCCmec types 
differ in location, but the same ST71 lineage is found in both Europe and East Asia, 
suggesting that ST71 is the most successful ST type in dogs. Since dogs do not travel to the 
same extent as humans, the mecA gene could possibly be carried to new geographic regions 
by human S. aureus. McCarthy et al. (2014) and Bannoehr et al. (2007) found the SCCmec 
element of S. pseudintemedius to highly match the SCCmec elements of S. aureus and other 
species of staphylococci, and thus believe in HGT between staphylococcal species, supporting 
the hypothesis of human carriage. However, both studies included samples from various 
different regions around the world, making it hard to draw certain conclusions.  
 
Wang et al. (2012) on the other hand present a view that differ from the ones presented in 
other studies (Bannoehr et al., 2007; McCarthy et al., 2014). Wang et al. compared the 
SCCmec type of MRSP found in canine patients with their previous study carried out in the 
same regions by Zhang et al. (2011) on SCCmec in S. aureus. They identified differences in 
SCCmec and concluded that SCCmec has not been acquired from S. aureus. However, the 
sample size was rather small (n=33, Wang et al., n=18, Zhang et al.). One can therefore 
question whether such conclusions can be drawn from the results. Also, the study population 
was different where Zhang et al. took samples from dogs, cats and veterinary staff (not 
specified whether healthy or diseased individuals), making the two studies incomparable. 
Moreover, the aim of the study by Zhang et al. was to investigate the occurrence of MRSA 
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in pets and veterinary staff, and not comparisons in SCCmec. Therefore, the different study 
designs of the two studies also make them less comparable. One should also bear in mind that 
the fact that HGT has not yet been found does not necessarily imply it not occurring.  
 
Loeffler et al. (2007) claim to have studied S. intermedius. However, only phenotypic 
speciation and not molecular analysis was carried out to identify the staphylococcal isolates as 
S. intermedius. Besides, at the beginning of the study 18 months earlier, S. pseudintermedius 
was just described as a novel species belonging to the SIG group together with S. intermedius 
and S. delphini. Since S. pseudintermedius is the most frequent species of the SIG group to 
colonize dogs, old reports on S. intermedius are considered to belong to the species S. 
pseudintermedius (Weese & van Duijkeren, 2010).  
 
That MRSP is becoming an increasing problem in veterinary medicine is evident, but its 
zoonotic role is not yet fully understood. The zoonotic aspect of MRSP is certainly of less 
importance than that of MRSA, since even colonization of S. pseudintermedius in humans is 
rare. One human case of MRSP has been reported, but it was not possible to say whether the 
infection came from an animal or not. However, if resistance genes can be acquired by human 
commensal S. aureus from canine MRSP, the zoonotic problem will become a serious threat 
to human. On the other hand, zoonoses can go both ways where humans can act as a source of 
infection for dogs. The selection pressure in human medicine is even greater due to the more 
extensive use of antibiotics. In some countries, certain antibiotics are restricted to human 
medicine (meaning that they are not available for the treatment of sick animals) and hence the 
problem in veterinary medicine may become more urgent. In any case, further studies are 
needed to investigate and fully understand the horizontal gene transfer of S. pseudintermedius 
SCCmec, e.g. by starting to study the mechanisms in vitro. 
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